Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study by Moor, C. C, Mostard, R. L. M, Grutters, J. C, Bresser, P, Aerts, J. G. J. V, Dirksen, C. D, Kimman, M. L, Wijsenbeek, M. S

Get full text

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis by Erckens, R. J., Mostard, R. L. M., Wijnen, P. A. H. M., Schouten, J. S., Drent, M.

Get full text

Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis by Mostard, R.L.M, Vöö, S, van Kroonenburgh, M.J.P.G, Verschakelen, J.A, Wijnen, P.A.H.M, Nelemans, P.J, Erckens, R.J, Drent, M

Get full text

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study by Kahlmann, Vivienne, Janssen Bonás, Montse, Moor, Catharina C, van Moorsel, Coline H. M, Kool, Mirjam, Kraaijvanger, Raisa, Grutters, Jan C, Overgaauw, Mayka, Veltkamp, Marcel, Wijsenbeek, Marlies S, Koopman, B, Geelhoed, J. J. M, Janssen, R, Jonkers, R.E, Kramer, H, Moonen, L, Mostard, R. L. M, Nossent, E. J, Overbeek, M. J, van Rijswijk, R.H. N. A. J, Wagenaar, M, Walen, S, Wielders, P. L. M. L, Loth, D. W, Bogaarts, B. A. H. A, van der Maten, J

Get full text

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study by Miedema, Jelle R, Moor, Catharina C, Veltkamp, Marcel, Baart, Sara, Lie, Natascha S L, Grutters, Jan C, Wijsenbeek, Marlies S, Mostard, Rémy L M

Get full text

The laboratory parameters-derived CoLab score as an indicator of the host response in ICU COVID-19 patients decreases over time: a prospective cohort study by Schoenmakers, Tom, Leers, Mathie P. G., Gorissen, Stefan H. M., van Loo, Inge H. M., van Rosmalen, Frank, Aydeniz, Eda, Schellens, Joep, Driessen, Marielle, Deneer, Ruben, de Venne, Wilhelmine P. H. G. Verboeket-van, Wolffs, Petra F. G., van Mook, Walther N. K. A., van Bussel, Bas C. T.

Get full text

Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more by Boone, Niels W, Moes, Dirk Jan A R, Ramiro, Sofia, Mostard, Remy L M, Magro-Checa, Cesar, van Dongen, Christel M P, Gronenschild, Michiel, van Haren, Eric, Buijs, Jacqueline, de Vries, Annick, Peeters, Ralph, Landewé, Robert B M, Wong, Dennis R

Get full text

Validating a clinical laboratory parameter-based deisolation algorithm for patients with COVID-19 in the intensive care unit using viability PCR: the CoLaIC multicentre cohort stud... by Schoenmakers, Tom, van Bussel, Bas C T, Gorissen, Stefan H M, van Loo, Inge H M, van Rosmalen, Frank, Verboeket-van de Venne, Wilhelmine P H G, Wolffs, Petra F G, van Mook, Walter N K A, Leers, Mathie P G, Ament, Stephanie MC, Sesmu Arbous, M, Bekers, Otto, Berkel, Miranda van, Boer, Arjen-Kars, Dam, Dirck W van, Deneer, Ruben, van Doorn, William PTM, Dormans, Tom P, Evers, Silvia MAA, Frenzel, Tim, Gillis, Judith, van der Horst, Iwan CC, Koek, W Nadia H, Linssen, Kitty CFM, Meex, Steven JR, Mostard, Guy JM, Mostard, Remy LM, Otterspoor, Luuk C, van Riel, Natal AW, Stals, Frans, Wolthuis, Albert

Get full text

Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire by Kimman, Merel L., Wijsenbeek, Marlies S., van Kuijk, Sander M. J., Wijnsma, Kioa L., van de Kar, Nicole C. A. J., Storm, Marjolein, van Jaarsveld, Xana, Dirksen, Carmen D.

Get full text